Popoff E - Search Results

1

Health State Utility Mapping of Rimegepant for the Preventive Treatment of Migraine: Double-Blind Treatment Phase and Open Label Extension (BHV3000-305).

Powell LC, L'Italien G, Popoff E, Johnston K, O'Sullivan F, Harris L, Croop R, Coric V, Lipton RB. Powell LC, et al. Among authors: popoff e. Adv Ther. 2023 Feb;40(2):585-600. doi: 10.1007/s12325-022-02369-x. Epub 2022 Nov 22. Adv Ther. 2023. PMID: 36417057 Free PMC article. Clinical Trial.

2

Aligning text mining and machine learning algorithms with best practices for study selection in systematic literature reviews.

Popoff E, Besada M, Jansen JP, Cope S, Kanters S. Popoff E, et al. Syst Rev. 2020 Dec 13;9(1):293. doi: 10.1186/s13643-020-01520-5. Syst Rev. 2020. PMID: 33308292 Free PMC article.

3

Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis.

Kanters S, Wilkinson L, Vrazic H, Sharma R, Lopes S, Popoff E, Druyts E. Kanters S, et al. Among authors: popoff e. BMJ Open. 2019 Jul 23;9(7):e023458. doi: 10.1136/bmjopen-2018-023458. BMJ Open. 2019. PMID: 31340953 Free PMC article.

4

Comparative efficacy of cemiplimab versus other systemic treatments for advanced cutaneous squamous cell carcinoma.

Keeping S, Xu Y, Chen CI, Cope S, Mojebi A, Kuznik A, Konidaris G, Ayers D, Sasane M, Allen R, Huynh TM, Popoff E, Freeman M, Andria ML, Fury MG, Singh K, Stockfleth E, Challapalli A, Schmults CD. Keeping S, et al. Among authors: popoff e. Future Oncol. 2021 Feb;17(5):611-627. doi: 10.2217/fon-2020-0823. Epub 2020 Oct 14. Future Oncol. 2021. PMID: 33052055 Free article.

5

Comparative efficacy and safety of second-line antiretroviral therapy for treatment of HIV/AIDS: a systematic review and network meta-analysis.

Kanters S, Socias ME, Paton NI, Vitoria M, Doherty M, Ayers D, Popoff E, Chan K, Cooper DA, Wiens MO, Calmy A, Ford N, Nsanzimana S, Mills EJ. Kanters S, et al. Among authors: popoff e. Lancet HIV. 2017 Oct;4(10):e433-e441. doi: 10.1016/S2352-3018(17)30109-1. Epub 2017 Aug 4. Lancet HIV. 2017. PMID: 28784426 Review.

6

Effect of frequency of clinic visits and medication pick-up on antiretroviral treatment outcomes: a systematic literature review and meta-analysis.

Mutasa-Apollo T, Ford N, Wiens M, Socias ME, Negussie E, Wu P, Popoff E, Park J, Mills EJ, Kanters S. Mutasa-Apollo T, et al. Among authors: popoff e. J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21647. doi: 10.7448/IAS.20.5.21647. J Int AIDS Soc. 2017. PMID: 28770599 Free PMC article. Review.

7

A US cost-minimization model comparing ravulizumab versus eculizumab for the treatment of atypical hemolytic uremic syndrome.

Wang Y, Johnston K, Popoff E, Myren KJ, Cheung A, Faria C, Tomazos I. Wang Y, et al. Among authors: popoff e. J Med Econ. 2020 Dec;23(12):1503-1515. doi: 10.1080/13696998.2020.1831519. Epub 2020 Nov 10. J Med Econ. 2020. PMID: 33001704 Free article.

8

Novel acute therapies in the treatment of migraine: impact of re-dosing on cost-utility outcomes.

Johnston KM, L'italien G, Harris L, Deighton A, Popoff E, Croop R, Coric V. Johnston KM, et al. Among authors: popoff e. J Med Econ. 2021 Jan-Dec;24(1):512-513. doi: 10.1080/13696998.2021.1915600. J Med Econ. 2021. PMID: 33843409 Free article. No abstract available.

9

Matching-adjusted indirect comparisons of oral rimegepant versus placebo, erenumab, and galcanezumab examining monthly migraine days and health-related quality of life in the treatment of migraine.

Popoff E, Johnston K, Croop R, Thiry A, Harris L, Powell L, Coric V, L'Italien G, Moren J. Popoff E, et al. Headache. 2021 Jun;61(6):906-915. doi: 10.1111/head.14128. Epub 2021 May 22. Headache. 2021. PMID: 34021585 Free PMC article.

10

Comparative efficacy and safety of rimegepant, ubrogepant, and lasmiditan for acute treatment of migraine: a network meta-analysis.

Johnston K, Popoff E, Deighton A, Dabirvaziri P, Harris L, Thiry A, Croop R, Coric V, L'Italien G, Moren J. Johnston K, et al. Among authors: popoff e. Expert Rev Pharmacoecon Outcomes Res. 2022 Jan;22(1):155-166. doi: 10.1080/14737167.2021.1945444. Epub 2021 Jul 2. Expert Rev Pharmacoecon Outcomes Res. 2022. PMID: 34148501 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

39 results

Search Page

Filters